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Abstract: Combining the concepts of synthetic symmetrization with the approach of engineering
metal-binding sites, we have developed a new crystallization methodology termed metal-mediated
synthetic symmetrization. In this method, pairs of histidine or cysteine mutations are introduced on
the surface of target proteins, generating crystal lattice contacts or oligomeric assemblies upon
coordination with metal. Metal-mediated synthetic symmetrization greatly expands the packing
and oligomeric assembly possibilities of target proteins, thereby increasing the chances of
growing diffraction-quality crystals. To demonstrate this method, we designed various T4 lysozyme
(T4L) and maltose-binding protein (MBP) mutants and cocrystallized them with one of three metal
ions: copper (Cu21), nickel (Ni21), or zinc (Zn21). The approach resulted in 16 new crystal
structures—eight for T4L and eight for MBP—displaying a variety of oligomeric assemblies and
packing modes, representing in total 13 new and distinct crystal forms for these proteins. We
discuss the potential utility of the method for crystallizing target proteins of unknown structure by
engineering in pairs of histidine or cysteine residues. As an alternate strategy, we propose that the
varied crystallization-prone forms of T4L or MBP engineered in this work could be used as
crystallization chaperones, by fusing them genetically to target proteins of interest.
Keywords: protein crystallization; protein design; metal binding; symmetry
Introduction
A common bottleneck in protein X-ray crystallogra-
phy is the ability to grow diffraction-quality crystals.
Although high-throughput robotics now makes it
possible to screen vast numbers of crystallization
conditions, some proteins remain recalcitrant to
crystallization. Many approaches have been devel-
oped to improve the success rate for crystallization,
for example, systematically truncating the target
protein,1,2 methylating the lysine residues,3,4 remov-
ing post-translational modifications,5–7 screening
homologues of the target protein for crystalliza-
tion,8,9 fusing the target protein to a carrier pro-
tein,10–13 crystallizing racemic mixtures of the target
protein,14–20 and cocrystallizing the target protein
with antibodies or other binding proteins.21–23 A
number of those methods have been reviewed.24
Recently, rational mutagenesis of protein sur-
face residues has been proposed to improve the crys-
tallizability of target proteins, including methods
referred to as ‘‘surface entropy reduction’’ (SER)25
and ‘‘synthetic symmetrization’’ (or crystal lattice en-
gineering).26–28 The SER method typically replaces
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solvent-exposed, flexible amino acids, such as Lys,
Glu, and Gln, with less flexible residues, such as
Ala. It has been successfully used for several protein
targets,29–31 and a web-based server has been cre-
ated to suggest suitable mutation sites in any given
protein sequence.30 Synthetic symmetrization
involves introducing into the surface of a protein
specific motifs likely to drive symmetric self-associa-
tion. Motivation for the approach derives in part
from the observation that protein oligomers tend to
crystallize in space groups that support the point
group symmetry of the oligomer.26 In such cases,
some of the contacts required to establish a crystal
lattice are essentially built in to the oligomer, mean-
ing that fewer fortuitous contacts are required.16
The general strategy is also amenable to variation;
different modes of engineered oligomerization lead
to distinctly different opportunities for crystalliza-
tion. One method already demonstrated for syntheti-
cally dimerizing a protein is to introduce a single
cysteine on the surface and then form an intermolec-
ular disulfide bond. That method was applied first to
crystallize bacteriophage T4 lysozyme (T4L) in sev-
eral new crystal forms26 and then to crystallize an
enzyme of previously unknown structure.27 In a par-
allel strategy (alternately coined crystal lattice engi-
neering), a series of surface-exposed helix residues
were mutated to leucine to promote dimerization by
way of an intermolecular leucine zipper28; a subse-
quent application of that approach produced crystals
by way of heterotypic interactions between the engi-
neered half-leucine zipper and a distinct surface
region from another protein molecule, rather than
by way of a symmetric self-association.32 Despite the
successes demonstrated so far by the disulfide- and
leucine-zipper-based approaches to synthetic sym-
metrization, they suffer from a limited type of sym-
metric association; both are designed to produce
dimers.
It is known that metals play a very important
role in oligomerization and crystallization of pro-
teins.33–35 For example, in the high-resolution crys-
tal structure of truncated alphaA crystallin,36 a zinc-
binding motif is formed by three chains, and zinc
promotes protein oligomerization and crystallization.
The compound tetrathiomolybdate, used in the treat-
ment of copper metabolism disorders, reacts with
the copper binding metallochaperone, Atx1, forming
a stable complex.37 The crystal structure of this com-
plex reveals a trimer of Atx1 molecules mediated
through the bound tetrathiomolybdate molecule.
Tezcan and coworkers38–42 have studied metal-
directed protein self-assembly on the model protein,
cytochrome b562, focusing primarily on the evolution
of metal coordination in protein folds and complexes.
Their work has shown that by introducing histidine
mutations on the alpha helical surface of cytochrome
b562, the protein can oligomerize to form dimers to
tetramers, all of which are mediated through metal
binding. Furthermore, the metals present within a
protein crystal can provide the experimental phases
needed for its structure determination.43 Although
the incorporation of selenomethionine into proteins
has become a standard method for exploiting anoma-
lous scattering information,44 natural metal-binding
sites containing copper, iron, nickel, cobalt, or zinc
atoms have also been utilized for protein structure
determination via anomalous dispersion (see Refs.
45–49 and references therein).
Here, we propose a new crystallization method-
ology, termed metal-mediated synthetic symmetriza-
tion, which combines the idea of synthetic symmetri-
zation with strategies—following work by Tezcan
et al.42—for engineering metal-binding sites at pro-
tein interfaces. This method has the potential to pro-
duce a variety of new crystal forms by introducing
new contacts between protein molecules in the lat-
tice through metal binding interactions, thereby
increasing the chances of obtaining diffraction-qual-
ity crystals. We demonstrate the applicability of
metal-mediated symmetrization using two proteins
commonly used as fusion partners for crystallization
trials: T4L and maltose-binding protein (MBP). We
discuss potential advantages of this method over
current approaches and ways to use the method on
proteins of unknown structure, through either direct
mutations on the target protein or fusion of the tar-
get protein to metal-site mutants of T4L or MBP,
which could serve as crystallization chaperones.
Results
Rationale and design of mutations
On the basis of previous studies regarding natural
or engineered metal-binding sites, we rationalized
that mutations of solvent-exposed residue pairs i
and i þ 4 of a helix50–53 or i and i þ 3 of a helix-
loop37 to a pair of either histidine or cysteine resi-
dues would induce homooligomeric assemblies upon
incubation with metal. Specifically, we predicted the
metal site within these assemblies to take on a
tetrahedral or octahedral coordination, in which the
mutated histidines or cysteines among the molecules
participate in the metal coordination. Such coordina-
tion geometries are commonly found in proteins33,54
and have been engineered previously.37–42 On the
basis of the crystal structures of T4L and MBP in
each protein, we chose three pairs of solvent-accessi-
ble residues that are located close to the ends of heli-
ces (Fig. 1). The introduction of metal-binding sites
near the ends of helices, compared with sites in the
middle of helices, was expected to cause fewer steric
clashes and allow greater coordination possibilities
among molecules. In both T4L and MBP, the muta-
tions were chosen to be distant from the C-terminus,
to avoid potential interference with a fusion protein
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that might be attached. The determination of which
residues are on the surface-exposed side of a helix
was straightforward in our test experiments with
T4L and MBP, whereas this represents a challenge
when the structure is unknown. A recent application
of disulfide-based synthetic symmetrization27 illus-
trates the use of sequence alignments and bioinfor-
matics tools to make reasonable choices for engineer-
ing residues on the sides of helices.
T4L and MBP mutants—most containing two
mutations and one containing four mutations (sum-
marized in Table I)—were expressed, purified, and
subjected to cocrystallization in the presence of
either copper (Cu2þ), nickel (Ni2þ), or zinc (Zn2þ).
The ratio of metal to protein was 1.5 to 1. In some
cases, the addition of metal induced slight precipita-
tion of the protein-metal solution that could be
reversed by the addition of EDTA. However, no addi-
tional purification step, besides filtration through a
0.22 lm membrane, was performed once the metal
was added (see Methods for details). Crystallization
was carried out using standard commercial crystalli-
zation screens (typically only three to four 96-well
experiments). For all of the mutant constructs, crys-
tals formed in a variety of conditions within 1 week,
and in some cases within 2 h, of setting up crystal
screens. All structures were solved from crystals
mounted from preliminary screens without any fur-
ther optimization (Supporting Information Table 3).
T4L histidine mutants
For T4L, we created two double-histidine mutants,
T4L76H/80H and T4L61H/65H, and one quadruple-histi-
dine mutant, T4L61H/65H/76H/80H, chosen to emulate
the engineering design by Tezcan et al.33 in which
four histidine mutations are introduced as two pairs
of proximal residues in a long helix. Crystallization
of these mutants with the various metals resulted in
eight crystal structures (Table I), which represent
six distinct crystal forms; in some mutants, nickel
and copper produced similar metal-binding sites and
crystal packing arrangements. The crystal forms
obtained were all different from those observed
before for T4L.55 The molecular structures and crys-
tal packing diagrams are shown in Figures 2 and 3,
and crystallographic statistics are shown in Support-
ing Information Table 1.
Different combinations of mutations and metals
led to various oligomeric forms of T4L. The protein
can form either dimers [Fig. 2(a–c,e)] or trimers
[Fig. 2(d)] through metal coordination, illustrating a
greater range of oligomerization possibilities com-
pared with other methods of symmetrization. More-
over, in one case, a metal-mediated dimer further
associated into a hexameric ring within the crystal
asymmetric unit [Fig. 2(e)]. With respect to metal
site formation, the crystallization results were like-
wise variable and unpredictable. The same mutant
sometimes crystallized in different forms in the pres-
ence of different metals [Fig. 2(a,e)] or even in differ-
ent forms with the same metal [Fig. 2(b,d)]. Unex-
pectedly, in some structures one of the mutated
histidines is not in coordination with the metal [Fig.
2(b–d)]. Instead, either natural (wild type) surface
residues or solvent molecules complete the coordina-
tion (Table I). However, in all of the cases where this
occurs, the neighboring free histidine is in a p stack-
ing arrangement with the coordinating histidine
[Fig. 2(b–d)], indicating it may be necessary for the
coordination. Finally, not all the T4L molecules in
the asymmetric unit are coordinated by the metals.
In two cases, a noncoordinated molecule is present
Figure 1. Surface residues of T4 lysozyme (T4L) and maltose-binding protein (MBP) selected for mutations. (a) T4L is
represented as a cartoon (blue). Three pairs of residues are labeled (red, yellow and green), each corresponding to one double-
residue mutant: D61/K65 to histidines, R125/E128 to cysteines, R76/R80 to either histidines or cysteines in two different
constructs. A quadruple histidine mutant for D61/K65/R76/R80 was also made. (b) MBP is represented as a cartoon (orange).
Three pairs of residues are labeled (green, blue and purple), each corresponding to one double histidine mutant. All selected
pairs are three or four residues apart and are close to the ends of helices. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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[Fig. 2(c,d)]. The variations in metal site geometry
and protein oligomerization enable the numerous
new crystal forms observed here for T4L (Table I
and Fig. 3).
MBP histidine mutants
To demonstrate that this methodology applies not
only to T4L but also to a second protein, MBP, we
prepared three double-histidine mutants of MBP –
MBP216H/220H, MBP26H/30H, and MBP310H/314H – and
crystallized them in the presence of metals (Table I).
The molecular structures and crystal packing dia-
grams of these mutants are shown in Figures 4 and
5, and crystallographic statistics are shown in Sup-
porting Information Table 2. Similar to T4L histi-
dine mutants, MBP mutants can either dimerize
[Fig. 4(a)] or trimerize [Fig. 4(e)] upon addition of
metal ions. In one case, a dinuclear zinc site is pres-
ent [Fig. 4(c)]. Notably for the MBP mutants, metal
coordination can be involved in lattice contacts and
drive the formation of metal-mediated polymers
[Figs.4(b–d) and 5]. Depending on the crystallization
conditions and type of metal, a single mutant con-
struct MBP216H/220H can pack into three different
forms [Fig. 4(a–c)]. Interestingly, in all the struc-
tures, natural surface residues, usually Glu and
Asp, participate in the coordination, and all mole-
cules in the asymmetric unit are coordinated by the
metals. The wild-type MBP construct used as the
starting point in this study crystallized exclusively
in space group P61 in previous work. The structures
of all the MBP mutants shown here are distinct
Figure 2. Crystal structures of metal-mediated symmetrization of T4 Lysozyme (T4L) histidine mutants. For each panel, a
close-up view of the metal binding site is shown as an inset with coordinating residues labeled. Copper and zinc atoms are
shown as bronze and grey spheres, respectively. Coordination to metal atoms is shown as dashed yellow lines. (a) The
mutated histidine residues of T4L76H/80H form a twofold NCS (noncrystallographic symmetry) dimer mediated through the
bound copper atom. T4L76H/80H has similar packing and interactions when cocrystallized with nickel (data not shown). Two
coordinating water molecules are shown in red. (b) The quadruple histidine mutant, T4L61H/65H/76H/80H, forms a dimer through
two copper atoms. Three mutated histidine residues, H61/H65/H76, and a natural aspartate, D72, complete each copper
binding site. (c) The double histidine mutant, T4L61H/65H, forms a dimer (purple and green) through two copper atoms. This
dimer is accompanied by a non-copper bound molecule (blue) packed within one asymmetric unit. Each copper site is
formed by one mutated histidine residue, H65, a natural glutamine, Q69, and completed by N-terminal glycine residues
derived from the tobacco etch virus (TEV) protease cleavage site. (d) The four histidine mutant, T4L61H/65H/76H/80H, also forms
a trimer. The copper binding site is formed by the mutated histidine, H61, located on a threefold crystallographic axis. Three
other protein molecules in the asymmetric unit, not bound to copper ions, are also shown (light yellow, light orange and light
red). (e) The double histidine mutant, T4L76H/80H, also forms a hexameric ring structure mediated by three zinc atoms. The
zinc binding sites are formed by two mutated histidine residues, H76/H80, from two neighboring molecules. [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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from the P61 crystal form obtained with wild-type
MBP and, therefore, represent new packing modes
driven by metal coordination.
T4L cysteine mutants
Considering that cysteine residues are also com-
monly found in coordination with metals—zinc fin-
ger proteins being a particularly well-studied
case54,56—we explored whether cysteine mutations
could also be used for metal-mediated symmetriza-
tion. We generated two double-cysteine mutants
of T4L: T4L76C/80C and T4L125C/128C (Fig. 6 and Sup-
porting Information Table 1) following the design
of an i and i þ 3 mutation at a helix-loop. The
T4L125C/128C mutant was inspired by the crystal
structure of copper-binding Atx1 in complex with
Figure 3. Crystal packing of T4L histidine mutants. (a–e) The crystal packings of five T4L histidine mutants are shown. The
annotation below each image indicates the construct, the cocrystallizing metal and the space group. The metal binding sites are
highlighted by red dots. Different chains in the asymmetric unit are colored differently. Molecules related by crystallographic
symmetry are shown in the same color. The packing arrangements are shown projected along one of the unit cell edges as
denoted by a coordinate system at the lower left corner of each image. A projection of the unit cell is also shown by a black
quadrilateral in each image. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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tetrathiomolybdate and copper, in which natural
Cys15 and Cys18 of Atx1 participate in a complex
metal binding network.37 Both mutants were puri-
fied in the presence of 1 mM dithiothreitol (DTT) to
prevent cysteine oxidation, and crystallization was
carried out in the presence of zinc. Interestingly,
T4L125C/128C crystallized as a trimer mediated by a
novel multinuclear zinc sulfur cluster, which to our
knowledge has not been reported previously [Fig.
6(a) and Supporting Information Fig. 1]. Four zinc
atoms form a tetrahedron with six sulfur atoms—
two from each protein—coordinating from six edges,
forming an adamantane-like cage. The zinc sulfur
cluster is reminiscent of the copper (Cu1þ) sulfur
cluster stabilized by Atx-1 and tetrathiomolybdate in
anaerobic conditions.37 The second double cysteine
mutant, T4L76C/80C, crystallized in more than 60% of
the crystallization conditions from an initial screen,
and some crystals diffracted to 1.5 A˚ without any
further optimization. The structure of this mutant
revealed a D2 tetramer covalently linked by four di-
sulfide bonds [Fig. 6(b)]. The tetramer is constituted
by two dimers that have similar structures to the
copper-bound T4L76H/80H [Fig. 2(a)]. The disulfide
bonds are all homotypic, with the two Cys76-Cys76
bonds lying on one dyad axis of symmetry and the
two Cys80-Cys80 bonds lying on one of the other
dyad axes. Surprisingly, no metal ions were observed
in the electron density, although zinc ions were
added to the crystallization drops. For both double
cysteine mutants of T4L, the crystal packing modes
are novel (Fig. 7), although in the second case, there
was no mediation through zinc.
Discussion
In this study, we demonstrate a crystallization
method that combines the concept of synthetic sym-
metrization with the approach of engineering metal
binding sites. We generated several different double
or quadruple histidine mutants of proteins T4L and
MBP, which were chosen in part for their prior use
as fusion proteins. On incubating these constructs
Figure 4. Crystal structures of metal-mediated symmetrization of maltose-binding protein (MBP) histidine mutants. The insets
show close-up views of the metal binding sites. Metal atoms are colored the same as described in Figure 1. Water and
chloride ions are shown as blue and green spheres, respectively. (a–c) A double histidine mutant, MBP216H/220H, forms a
variety of metal mediated interactions. (a) A copper mediated dimer is formed through the mutated histidine, H216, the natural
histidine, H40, and glutamate, E222, residues. (b) A polymeric assembly is created through crystal lattice contacts mediated
by zinc atoms. The zinc binding site is formed by the mutated histidine, H216, and the natural glutamate residues, E39/E222.
(c) Crystal lattice contacts are produced through zinc binding. Two zinc atoms are bound by the two mutated histidines,
H216/H220, the two natural glutamates, E222/E310, and also by acetate ions (orange). The MBP216H/220H mutant protein
displays the versatility of metal binding through use of different metals. (d) Crystal lattice contacts are mediated through zinc
atoms for the double histidine mutant, MBP26H/30H. The two mutated histidines, H26/H30, and the natural aspartate, D165,
form the zinc binding site. (e) The double histidine mutant, MBP310H/314H, forms a trimer assembled through three zinc atoms.
Two natural glutamates, E292/E289, and the mutated histidines, H310/H314, complete each zinc binding site. [Color figure
can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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with various metals (Cu2þ, Ni2þ, and Zn2þ), we
obtained 14 new crystal structures, representing 11
new and distinct crystal forms, showing various
symmetries and packing modes mediated by the
added metal ions (Table I). Moreover, we crystallized
two different double cysteine mutants of T4L with
added zinc ions, and obtained two further distinct
crystal forms exhibiting more complex packing
arrangements, in one case based on direct disulfide
bonding rather than metal-mediated interactions.
We obtained crystals with new symmetry and
packing from all the mutation pairs we tested. Some
mutants crystallized with great ease and variety.
For example, MBP216H/220H and T4L61H/65H/76H/80H
could be crystallized in many different forms,
depending on the crystallization condition and the
type of metal. Crystals having the same unit cell
dimensions and symmetry as the wild-type protein
(P3221 for T4L and P61 for MBP) were also some-
times obtained, but at a relatively low rate (less
Figure 5. Crystal packing of MBP histidine mutants. (a–e) Crystal packings of five MBP histidine mutants are shown. The
annotation below each image indicates the construct, the cocrystallizing metal and the space group. The metal binding sites
are highlighted by red dots. Different chains in the asymmetric unit are colored differently in panels a, d, and e. Molecules
related by crystallographic symmetry are shown in the same color. The packing arrangements are shown projected along one
of the unit cell edges as denoted by a coordinate system at lower left corner of each image. A projection of the unit cell is
also shown by a black quadrilateral in each image. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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than 1/3 of the time). Analysis of the crystallization
conditions for all mutants (Supporting Information
Table 3) shows that conditions that facilitated metal-
mediated oligomeric assembly tended to either have
high concentrations of salt or polyethylene glycol of
various molecular weights.
The metal ions were incorporated into the crystal
lattice in different ways in different crystals. In a
number of structures, the metal fell on a crystallo-
graphic axis (Table I), suggesting that the metal-
induced homooligomeric assembly helped drive lattice
formation. This is especially apparent in the poly-
meric assemblies of MBP216H/220H and MBP26H/30H in
the presence of zinc (Fig. 5), in which metal coordina-
tion generates helical arrangements of subunits com-
patible with crystal symmetry. Both types of situation
support the notion that symmetrized oligomers may
gain an advantage over asymmetric monomers in crys-
tal formation. We note that in all the crystal structures
obtained, despite the variety of protein oligomeric
states induced, that generally the individual metal
ions added were coordinated by two subunits. We also
observed that in slightly more than half of the struc-
tures, only one of the two introduced histidines partici-
pated in the coordination. In those cases, natural sur-
face residues, usually Glu or Asp, or solvent molecules
were involved in metal binding instead. This suggests
the possibility in future work of combining Glu and
Asp with single or double His mutations for metal-
mediated synthetic symmetrization.
The oligomeric protein arrangements observed
by metal-mediated symmetrization were highly
variable. It is likely that even greater diversity
could have been realized through additional
Figure 6. Crystal structures of metal-mediated symmetrization of T4 Lysozyme (T4L) double cysteine mutants. (a) The double
cysteine mutant, T4L125C/128C, forms a trimeric complex assembled through a zinc cluster. Three pairs of cysteines from
neighboring molecules coordinate four zinc atoms in an adamantane-like structure stabilized by four chloride ions (shown in
the inset). (b) A covalent tetramer is formed by the double cysteine mutant, T4L76C/80C, through disulfide bonds. Shown are
four molecules related by D2 (or 222) symmetry. Four disulfide bonds between the mutated cysteines, C76 and C80,
covalently link the four protein molecules into a ring. The disulfide bonds are highlighted in the inset. [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
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investigations. For several constructs, there were too
many favorable leads from initial crystallization tri-
als to permit a complete characterization of all the
possible crystal forms. Furthermore, other experi-
mental variables that might have produced addi-
tional crystal forms were not investigated. The rela-
tive concentration of metal ions was held fixed in
our experiments, although this variable might be
expected to influence the oligomeric modes of metal-
mediated protein association.
Polymorphic assembly behavior was also ob-
served under different crystallization conditions for
some individual combinations of protein constructs
and metals. This was evident in the multiple struc-
tures of T4L61H/65H/76H/80H with copper, for example,
in which slight variations in the crystallization
conditions (Supporting Information Table 3) led to
outcomes in which the geometry of the metal coordi-
nation by T4L molecules varied from square planar
to tetrahedral [Table I and Fig. 2(b,d)]. In such
cases, alternate metal-driven protein arrangements
may be favored by slightly different solution condi-
tions, or by different crystal packing arrangements.
The likelihood that multiple distinct arrangements
coexist in solution in some cases raises the possibil-
ity that heterogeneity could hinder crystallization.
However, the multitude of our successful crystalliza-
tion results, including multiple distinct forms from
some individual combinations of protein construct
and metal ion, argues otherwise. The reversibility of
metal coordination probably has a positive effect in
this regard, making it possible for favorable crystal
packing arrangements to drive otherwise heteroge-
neous mixtures into specific, well-ordered crystal
forms. Furthermore, the coordination geometries of
the metal sites were often slightly distorted (Table
I), suggesting that flexibility in metal coordination
could also help enable the formation of well-ordered
crystal packing arrangements.
Another potential advantage of metal-mediated
synthetic symmetrization is the phasing power intro-
duced by metals. The metal sites are well defined
in most of our structures (Supporting Information
Table I and II), and anomalous signals were
observed for most of them, despite that the data were
not collected using an X-ray wavelength close to the
absorption edge for the metals introduced (Support-
ing Information Fig. 1). For the T4L125C/128C mutant,
we confirmed that experimental phases could be
obtained using the anomalous scattering from the
zinc atoms (Supporting Information Fig. 1). By using
synchrotron radiation tuned to the optimal wave-
length, we anticipate that it will be generally possible
to obtain diffraction phases from crystals grown by
the metal-mediated symmetrization approach.
On the basis of our findings, we propose that
one could utilize the concept of metal-mediated syn-
thetic symmetrization to crystallize more difficult
protein targets that have eluded crystallization
using traditional methodologies. Figure 8 summa-
rizes the ‘‘rational mutagenesis of surface residues’’
methods that have been developed to facilitate pro-
tein crystallization. In contrast to previously pro-
posed methods, our approach allows the formation of
Figure 7. Crystal packing of T4L cysteine mutants (a and
b). Crystal packings of two T4L cysteine mutants are
shown. The annotation below each image indicates the
construct, the cocrystallizing metal and the space group.
The metal binding sites are highlighted by red dots. Note
that the packing of T4L76C/80C is mediated by disulfide
bonds instead of metals. Different chains in the asymmetric
unit are colored differently in panel a. Molecules related by
crystallographic symmetry are shown in the same color.
The packing arrangements are shown projected along one
of the unit cell edges as denoted by a coordinate system at
lower left corner of each image. A projection of the unit cell
is also shown by a black quadrilateral in each image. [Color
figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
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oligomers in diverse arrangements and symmetries,
giving rise to greatly expanded opportunities to
grow diffraction-quality crystals. The flexibility of
our approach also allows it to be potentially com-
bined with methods such as SER in which high-en-
tropy surface residues can be mutated.
We propose two variations by which the
approach could be used to promote the crystalliza-
tion of new target proteins: (i) crystallizing fusion
constructs in which a target protein is fused to the
various engineered forms of T4L or MBP described
here, or (ii) directly crystallizing a target protein
after mutating pairs of surface residues to histidine
or cysteine. The first approach is based on the obser-
vation that both T4L and MBP have been success-
fully used to crystallize otherwise difficult proteins,
including membrane proteins and amyloid pro-
teins.10,57–61 The mutation pairs characterized in
this study could be readily used to increase the
chance of getting crystals. The crystal packing
arrangements of such fusion proteins would depend
on surface properties of the target protein and would
therefore likely be different from the structures pre-
sented here. In the second, direct approach, posi-
tions for making mutation pairs in a target protein
would be chosen based on predictions of secondary
structure and surface exposure, or based on a homo-
logy model, when available. Double histidine or cys-
teine mutations are preferably introduced close to
the ends of a helix (Fig. 1). For long helices, two his-
tidine pairs can be introduced at both ends. The
spacing between the two histidines are preferably i
and i þ 4, and for cysteines either i and i þ 3 or i
and i þ 4. Theoretically, histidine mutations should
have a broader application, because they will not
interfere with native cysteines. Although additional
purification of oligomeric species after metal addi-
tion was not necessary for success in our studies,
this step might be useful in confirming metal-medi-
ated assembly and optimizing the chances of success
with more difficult protein targets.
Considering that it is easy to introduce double
mutations, and all the crystals in this study were
solved directly from robotic screens without any opti-
mization, one could apply the approach relatively
easily to generate and test several varied constructs
for a given protein of interest. Such an approach
could prove valuable for crystallizing asymmetric
proteins or protein complexes that have eluded tra-
ditional crystallization methodologies.
Methods
T4L plasmid construction
Cysteine-less T4L (a kind gift from Mark Fleissner
and Wayne Hubbell at UCLA), residues 1–162, was
PCR amplified with Platinum Taq Polymerase (Invi-
trogen, Carlsbad, CA). The N-terminal primers con-
tained a six base pair overhang, NdeI restriction site,
TEV protease cleavage site, and a short linker of resi-
dues GP to aid TEV protease cleavage. The C-termi-
nal primer contained a stop codon, XhoI restriction
site, and a three base pair overhang. The PCR prod-
uct was agarose gel purified and extracted using the
QIAquick Gel Extraction Kit (Qiagen, Valencia, CA).
Purified PCR product and pET28b (Novagen, Gibbs-
town, NJ) were digested with NdeI and XhoI accord-
ing to manufacturer protocol (New England Biolabs,
Ipswich, MA). Digested pET28b and T4L products
were gel purified and extracted (as described above).
DNA concentrations were determined using BioPho-
tometer UV/VIS Photometer (Eppendorf, Westbury,
NY). The vector pET28 and T4L were ligated using
the Quick Ligation Kit (New England Biolabs, Ips-
wich, MA) according to manufacturer protocol, and
transformed into E. coli cell line TOP10 (Invitrogen,
Carlsbad, CA). A colony was grown overnight, and
the pET28-TEV-T4L plasmid was purified using
QIAprep Spin Miniprep Kit (Qiagen, Valencia, CA).
T4L and MBP mutants
All mutations in the DNA sequence were performed on
the pET28-TEV-T4L or the pMal-a1 (a kind gift from
Figure 8. A scheme summarizing approaches for
crystallizing protein targets by rational mutagenesis of
surface residues. A protein (red box) can be mutated
according to the idea of ‘‘surface entropy reduction"30
(orange box), which typically involves replacing long flexible
amino acid side chains by alanine. Alternatively, or in
combination, surface residues can be modified in a way
that specifically promotes symmetric oligomerization. This
general idea is referred to as ‘‘synthetic symmetrization"26;
a closely related idea has been called ‘‘crystal lattice
engineering.’’28 Single cysteine mutations have been used
successfully for dimerization26,27 (green box). A method
based on inserting multiple leucine residues in a surface
helix has been used successfully by others (blue box).28,32
In this work we propose metal-mediated synthetic
symmetrization (purple boxes), which involves introducing
either double histidine mutations (lower right box) or double
cysteine mutations (lower left box), followed by the addition
of metal ions. The metal-mediated approach leads to a rich
variety of oligomeric arrangements and crystal packing
opportunities. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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Prof. Cynthia Wolberger at Johns Hopkins University)
plasmids using a Site-Directed Mutagenesis kit (Quick-
Change II XL, Agilent, Santa Clara, CA) with site-
directed primers designed using manufacturers Quick-
Change Primer Design Program available online (Agi-
lent, Santa Clara, CA), according to the manufacturer’s
protocol. The final constructs were sequenced prior to
transformation into E. coli expression cell line BL21
(DE3) gold cells (Novagen, Gibbstown, NJ).
Protein expression
A single colony was inoculated into LB Miller Broth
(Fisher BioReagents, Fisher Scientific, Pittsburgh, PA)
supplemented with 30 lg/mL Kanamycin (Fisher Sci-
entific, Pittsburgh, PA; LBKan) or 100 lg/mL Ampicil-
lin (Fisher Scientific, Pittsburgh, PA; LBAmp) for T4L
and MBP mutants, respectively. One liter of LBKan or
LBAmp in a 2-L shaker flask was inoculated with 7
mL of overnight culture and grown at 37C until the
culture reached an OD600 ¼ 0.6–0.8. For T4L
mutants, isopropyl b-D-1-thiogalactopyranoside (IPTG)
was added to a final concentration of 0.5 mM, and
grown for 1.5 h at 37C. For MBP mutants, IPTG was
added to a final concentration of 1 mM, and grown for
4 h at 37C. Cells were harvested by centrifugation at
5,000g for 10 min at 4C. The cell pellet was frozen
and stored at 80C prior to purification.
T4L protein purification
The cell pellet was thawed and resuspended in
buffer A [50 mM sodium phosphate, 0.3M sodium
chloride, and 20 mM imidazole (pH ¼ 8.0)] supple-
mented with Halt Protease Inhibitor Cocktail (Peirce,
Thermo Fisher Scientific, Rockford, IL) and 1 mM
DTT for cysteine containing mutants at 25 mL per 1
L of culture volume. The resuspended was culture
sonicated and centrifuged at 12,000g for 25 min at
4C. The clarified lysate was filtered through a 0.45-
lm syringe filtration device (HPF Millex-HV, catalog
no. SLHVM25NS, Millipore, Billerica, MA) before
loading onto a 5-mL HisTrap-HP column (GE Health-
care, Piscataway, NJ). The HisTrap-HP column was
washed with five column volumes of buffer A and
protein eluted with linear gradient to 100% in four
column volumes of buffer B [50 mM sodium phos-
phate, 0.3M sodium chloride, and 500 mM imidazole,
(pH ¼ 8.0)]. For cysteine containing mutants, buffers
A and B were supplemented with 5 mM beta-mercap-
toethanol (BME). Protein eluted around 40–60%
buffer B and peak fractions were pooled. TEV prote-
ase, produced and purified as described,36 was added
at a volume of 1/100th the pooled volume, and ethyle-
nediaminetetraacetic acid (EDTA) was added to final
concentration of 1 mM. After 20–30 min, pooled pro-
tein was transferred to a Slide-A-Lyzer 10,000
MWCO dialysis cassette (Pierce, Thermo Fisher Sci-
entific, Rockford, IL), and dialyzed against buffer C
(20 mM TRIS pH 8.0, 200 mM sodium chloride, 20
mM imidazole, 1 mM DTT) at room temperature
overnight. The dialyzed protein fraction was trans-
ferred to a 50 mL conical falcon tube (Fisher Scien-
tific, Pittsburgh, PA). After 2 days of TEV protease
cleavage, cut protein was passed over a 5 mL
HisTrap HP column pre-equilibrated in buffer A and
the flow-through containing His-tag removed T4L
was collected and concentrated prior to loading onto a
Superdex Prep Grade 75 gel filtration column equili-
brated in GF buffer [100 mM sodium chloride, 1 mM
DTT, and 20 mM TRIS (pH ¼ 8.0)]. Peak fractions
were pooled and concentrated. Protein concentration
was determined by UV absorbance at 280 nm with
extinction coefficient of 24750 M1 cm1 of protein.
MBP protein purification
Cells were resuspended in a lysis buffer containing
100 mM Tris-HCl (pH ¼ 8.0), 100 mM NaCl, and 1
mM EDTA. Phenylmethylsulfonyl fluoride (PMSF)
was added to the cell resuspension to a final concen-
tration of 1 mM. Clarified cell lysate, as described
above, was loaded onto a self-packed amylose
column (150 mL column volume, resin from New
England Biolabs, Ipswich, MA). The column was
first washed with Buffer A [20 mM Tris-HCl (pH ¼
8.0) and 100 mM NaCl] for one column volume and
then eluted with Buffer B [20 mM Tris-HCl (pH ¼
8.0), 100 mM NaCl, and 10 mM maltose]. Peak frac-
tions were pooled and concentrated using an Amicon
Ultra-15 concentrator (30 kDa MW cutoff; Millipore,
Billerica, MA) prior to loading onto a Superdex S-
200 column (GE Healthcare, Piscataway, NJ) equili-
brated in SEC buffer [20 mM Tris-HCl (pH ¼ 8.0),
100 mM NaCl, and 5 mM maltose]. Peak fractions
were pooled and concentrated. Protein concentration
was determined by absorbance at 280 nm with the
calculated extinction coefficient of 67800 M1 cm1.
Protein crystallization
Concentrated T4L and MBP protein mutants were
diluted to  1 mM and supplemented with 1.25–1.5
mM of metal: copper sulfate, nickel sulfate, or zinc
acetate. Protein solutions containing metals were fil-
tered through a 0.22 lm Ultrafree-MC centrifugal
filter device (Amicon, Bedford, MA) prior to crystalli-
zation experiments in hanging drop plates. Crystalli-
zation experiments were carried out at the UCLA
crystallization core facility (http://www.doe-mbi.
ucla.edu/facilities/crystallization) and stored at 20C.
The crystallization conditions are provided in
Supporting Information Table 3.
Structure determination
All data were collected at 100 K at Advanced Photon
Source (Chicago, IL) beam lines 24-ID-C and 24-ID-
E, and in-house on a Rigaku Raxis-IVþþ imaging
plate detector using Cu Ka radiation from a Rigaku
FREþ rotating anode generator with confocal optics
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(Supporting Information Table 1). Single crystals
were cryoprotected with glycerol and mounted with
CrystalCap HT Cryoloops (Hampton Research, Aliso
Viejo, CA). Crystals were flash-cooled in liquid nitro-
gen prior to data collection. All data were processed
using DENZO/SCALEPACK62 or XDS/XSCALE.63
Initial phases of T4L and MBP mutants were calcu-
lated by molecular replacement using structures
with PDB codes 3LZM and 1ANF, respectively, as
search models using PHASER.64 Model building was
done using COOT.65 All model refinement was done
using REFMAC,66 PHENIX,67 and BUSTER.68
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